Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis. CI [Internet]. 2026 Feb. 4 [cited 2026 Jul. 11];2(1). Available from: https://www.cheminters.com/index.php/jci/article/view/58